About Embr Labs
Embr Labs is a private company based in Boston, Massachusetts. It has reported $14,134,042 raised in four offerings on Form D since January 2015. Its chief executive is Elizabeth Gazda.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 16, 2024 | Oct 30, 2024 | $3,000,000of $6.0M target | 2 | $1.5M | EquityRule 506(b) | Form D ↗ |
| Sep 29, 2021 | Oct 7, 2021 | $5,974,049of $22.9M target | 11 | $543K | EquityRule 506(b) | Form D ↗ |
| Sep 6, 2019 | Sep 17, 2019 | $5,059,993of $6.0M target | 11 | $459K | EquityRule 506(b) | Form D ↗ |
| Jan 5, 2015 | Jan 16, 2015 | $100,000of $1.5M target | 1 | $100K | DebtRule 506(b) | Form D ↗ |
| Total, four offerings | $14,134,042 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Embr Labs's Form D filed Oct 30, 2024.
Earlier filings also listed Natalie Lorenz-Anderson (director, last listed Oct 2021), Matthew Smith (executive officer and director, last listed Oct 2021), Bruce Clarke (director, last listed Oct 2021), Alex Waldron (director, last listed Oct 2021), David Cohen-Tanugi (executive officer, last listed Sep 2019) and Michael Gibson (executive officer and director, last listed Jan 2015).